This report contains market size and forecasts of Varicella Virus(Chickenpox) Vaccine in global, including the following market information:
Global Varicella Virus(Chickenpox) Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Varicella Virus(Chickenpox) Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Varicella Virus(Chickenpox) Vaccine companies in 2021 (%)
The global Varicella Virus(Chickenpox) Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monovalent Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Varicella Virus(Chickenpox) Vaccine include GSK, Merck & Co., Sanofi Pasteur, Green Cross, Shanghai Institute, BCHT, Changsheng, Keygen and Biken. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Varicella Virus(Chickenpox) Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Varicella Virus(Chickenpox) Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Varicella Virus(Chickenpox) Vaccine Market Segment Percentages, by Type, 2021 (%)
Monovalent Vaccine
Combination Vaccine
Global Varicella Virus(Chickenpox) Vaccine Market, by User, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Varicella Virus(Chickenpox) Vaccine Market Segment Percentages, by User, 2021 (%)
Children
Teenagers
Adults
Global Varicella Virus(Chickenpox) Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Varicella Virus(Chickenpox) Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Varicella Virus(Chickenpox) Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Varicella Virus(Chickenpox) Vaccine revenues share in global market, 2021 (%)
Key companies Varicella Virus(Chickenpox) Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Varicella Virus(Chickenpox) Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Merck & Co.
Sanofi Pasteur
Green Cross
Shanghai Institute
BCHT
Changsheng
Keygen
Biken